Ligand Conformational Bias Drives Enantioselective Modification of a Surface-Exposed Lysine on Hsp90

被引:42
作者
Cuesta, Adolfo [1 ]
Wan, Xiaobo [1 ,2 ]
Burlingame, Alma L. [2 ]
Taunton, Jack [1 ]
机构
[1] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
关键词
INHIBITOR; CANCER;
D O I
10.1021/jacs.9b09684
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Targeted covalent modification of surface-exposed lysines is challenging due to their low intrinsic reactivity and high prevalence throughout the proteome. Strategies for optimizing the rate of covalent bond formation by a reversibly bound inhibitor (k(inact)) typically involve increasing the reactivity of the electrophile, which increases the risk of off-target modification. Here, we employ an alternative approach for increasing k(inact) of a lysine targeted covalent Hsp90 inhibitor, independent of the reversible binding affinity (K-i) or the, intrinsic electrophilicity. Starting with a noncovalent ligand, we appended a chiral, conformationally constrained linker, which orients an arylsulfonyl fluoride to react rapidly and enantioselectively with LysS8 on the surface of Hsp90. Biochemical experiments and high-resolution crystal structures of covalent and noncovalent ligand/Hsp90 complexes provide mechanistic insights into the role of ligand conformation in the observed enantioselectivity. Finally, we demonstrate selective covalent targeting of cellular Hsp90, which results in a prolonged heat shock response despite concomitant degradation of the covalent ligand/Hsp90 complex. Our work highlights the potential of engineering ligand conformational constraints to dramatically accelerate covalent modification of a distal, poorly nucleophilic lysine on the surface of a protein target.
引用
收藏
页码:3392 / 3400
页数:9
相关论文
共 32 条
  • [1] Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach
    Baggio, Carlo
    Gambini, Luca
    Udompholkul, Parima
    Salem, Ahmed F.
    Aronson, Alexander
    Dona, Ada
    Troadec, Estelle
    Pichiorri, Flavia
    Pellecchia, Maurizio
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (14) : 6350 - 6363
  • [2] Targeted Covalent Inhibitors for Drug Design
    Baillie, Thomas A.
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (43) : 13408 - 13421
  • [3] Discovery of 1-{(3R,4R)-3[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants
    Cheng, Hengmiao
    Nair, Sajiv K.
    Murray, Brion W.
    Almaden, Chau
    Bailey, Simon
    Baxi, Sangita
    Behenna, Doug
    Cho-Schultz, Sujin
    Dalvie, Deepak
    Dinh, Dac M.
    Edwards, Martin P.
    Feng, Jun Li
    Ferre, Rose Ann
    Gajiwala, Ketan S.
    Hemkens, Michelle D.
    Jackson-Fisher, Amy
    Jalaie, Mehran
    Johnson, Ted O.
    Kania, Robert S.
    Kephart, Susan
    Lafontaine, Jennifer
    Lunney, Beth
    Liu, Kevin K-C.
    Liu, Zhengyu
    Matthews, Jean
    Nagata, Asako
    Niessen, Sherry
    Ornelas, Martha A.
    Orr, Suvi T. M.
    Pairish, Mason
    Planken, Simon
    Ren, Shijian
    Richter, Daniel
    Ryan, Kevin
    Sach, Neal
    Shen, Hong
    Smeal, Tod
    Solowiej, Jim
    Sutton, Scott
    Tran, Khanh
    Tseng, Elaine
    Vemier, William
    Walls, Marlena
    Wang, Shuiwang
    Weinrich, Scott L.
    Xin, Shuibo
    Xu, Haiwei
    Yin, Min-Jean
    Zientek, Michael
    Zhou, Ru
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (05) : 2005 - 2024
  • [4] Structural bioinformatics-based design of selective, irreversible kinase inhibitors
    Cohen, MS
    Zhang, C
    Shokat, KM
    Taunton, J
    [J]. SCIENCE, 2005, 308 (5726) : 1318 - 1321
  • [5] Lysine-Targeted Inhibitors and Chemoproteomic Probes
    Cuesta, Adolfo
    Taunton, Jack
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, VOL 88, 2019, 88 : 365 - 381
  • [6] Selectively Targeting the Kinome-Conserved Lysine of PI3Kδ as a General Approach to Covalent Kinase Inhibition
    Dalton, Samuel E.
    Dittus, Lars
    Thomas, Daniel A.
    Convery, Maire A.
    Nunes, Joao
    Bush, Jacob T.
    Evans, John P.
    Werner, Thilo
    Bantscheff, Marcus
    Murphy, John A.
    Campos, Sebastien
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (03) : 932 - 939
  • [7] MAPPING HUMAN-BRAIN MONOAMINE OXIDASE-A AND OXIDASE-B WITH C-11 LABELED SUICIDE INACTIVATORS AND PET
    FOWLER, JS
    MACGREGOR, RR
    WOLF, AP
    ARNETT, CD
    DEWEY, SL
    SCHLYER, D
    CHRISTMAN, D
    LOGAN, J
    SMITH, M
    SACHS, H
    AQUILONIUS, SM
    BJURLING, P
    HALLDIN, C
    HARTVIG, P
    LEENDERS, KL
    LUNDQVIST, H
    ORELAND, L
    STALNACKE, CG
    LANGSTROM, B
    [J]. SCIENCE, 1987, 235 (4787) : 481 - 485
  • [8] Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues
    Gambini, Luca
    Baggio, Carlo
    Udompholkul, Parima
    Jossart, Jennifer
    Salem, Ahmed F.
    Perry, J. Jefferson P.
    Pellecchia, Maurizio
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (11) : 5616 - 5627
  • [9] Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology
    Gehringer, Matthias
    Laufer, Stefan A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (12) : 5673 - 5724
  • [10] Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
    Grimster, Neil P.
    Connelly, Stephen
    Baranczak, Aleksandra
    Dong, Jiajia
    Krasnova, Larissa B.
    Sharpless, K. Barry
    Powers, Evan T.
    Wilson, Ian A.
    Kelly, Jeffery W.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2013, 135 (15) : 5656 - 5668